JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5451
ProShares UltraShort S&P500
SDS
$346M
| $123K | ﹤0.01% |
1,249
-368
| -23% | -$36.4K |
2023 Q1
7 quarters
|
|
5452
Innovator Laddered Allocation Power Buffer ETF
BUFF
$1.06B
| $123K | ﹤0.01% |
2,731
| – | – |
2023 Q2
6 quarters
|
|
5453
Innovator Power Buffer Step-Up Strategy ETF
PSTP
$133M
| $122K | ﹤0.01% |
3,820
+1,555
| +69% | +$49.7K |
2023 Q3
5 quarters
|
|
|
BRW
5454
Saba Capital Income & Opportunities Fund
BRW
$309M
| $122K | ﹤0.01% |
16,008
| – | – |
2013 Q2
46 quarters
|
|
5455
FT Vest US Equity Buffer ETF August
FAUG
$1.37B
| $122K | ﹤0.01% |
2,613
-4,907
| -65% | -$228K |
2024 Q3
1 quarter
|
|
5456
BlackSky Technology
BKSY
$909M
| $121K | ﹤0.01% |
11,250
+4,983
| +80% | +$42.7K |
2023 Q2
6 quarters
|
|
5457
Quantum-Si Incorporated
QSI
$315M
| $121K | ﹤0.01% |
44,857
-184
| -0.4% | -$216 |
2021 Q4
12 quarters
|
|
5458
Frontline
FRO
$11.6B
| $120K | ﹤0.01% |
8,491
-607,912
| -99% | -$11.4M |
2013 Q2
46 quarters
|
|
|
DQ
5459
Daqo New Energy
DQ
$743M
| $120K | ﹤0.01% |
6,187
-80,880
| -93% | -$1.65M |
2019 Q4
20 quarters
|
|
5460
C4 Therapeutics
CCCC
$388M
| $120K | ﹤0.01% |
33,409
+7,630
| +30% | +$37.9K |
2020 Q4
16 quarters
|
|
5461
BNY Mellon US Large Cap Core Equity ETF
BKLC
$5.87B
| $120K | ﹤0.01% |
3,210
-1,425
| -31% | -$53.4K |
2024 Q2
2 quarters
|
|
5462
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
| $120K | ﹤0.01% |
6,152
-135,112
| -96% | -$2.64M |
2024 Q1
3 quarters
|
|
5463
Cadiz
CDZI
$323M
| $120K | ﹤0.01% |
23,013
+731
| +3% | +$2.63K |
2023 Q2
6 quarters
|
|
5464
ReposiTrak
TRAK
$146M
| $119K | ﹤0.01% |
5,397
+202
| +4% | +$4.28K |
2020 Q2
18 quarters
|
|
|
HIMX
5465
Himax Technologies
HIMX
$2.66B
| $119K | ﹤0.01% |
14,791
-149,335
| -91% | -$942K |
2021 Q1
15 quarters
|
|
5466
PepGen
PEPG
$159M
| $119K | ﹤0.01% |
31,287
+4,676
| +18% | +$29.1K |
2022 Q2
10 quarters
|
|
|
LAZR
5467
DELISTED
Luminar Technologies
LAZR
| $118K | ﹤0.01% |
21,929
-1,522
| -6% | -$16.1K |
2021 Q1
15 quarters
|
|
5468
Sutro Biopharma
STRO
$257M
| $118K | ﹤0.01% |
6,405
+511
| +9% | +$15.6K |
2018 Q3
25 quarters
|
|
5469
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.17B
| $118K | ﹤0.01% |
2,741
-1,181
| -30% | -$53.7K |
2017 Q4
28 quarters
|
|
5470
FT Vest US Equity Buffer ETF April
FAPR
$1.34B
| $117K | ﹤0.01% |
2,841
+2,741
| +2,741% | +$112K |
2024 Q2
2 quarters
|
|
5471
Inhibrx
INBX
$1.43B
| $117K | ﹤0.01% |
7,592
+2,457
| +48% | +$37.4K |
2024 Q2
2 quarters
|
|
5472
FT Vest Fund of Nasdaq-100 Buffer ETFs
BUFQ
$1.69B
| $117K | ﹤0.01% |
3,710
+2,080
| +128% | +$64.6K |
2024 Q3
1 quarter
|
|
5473
ALPS Smith Core Plus Bond ETF
SMTH
$3.59B
| $115K | ﹤0.01% |
+4,492
| New | +$116K |
2024 Q4
0 quarters
|
|
5474
Frequency Electronics
FEIM
$970M
| $114K | ﹤0.01% |
6,161
+4,860
| +374% | +$68.3K |
2023 Q3
5 quarters
|
|
5475
Franklin FTSE Australia ETF
FLAU
$201M
| $114K | ﹤0.01% |
4,067
-1,598
| -28% | -$48.6K |
2022 Q4
8 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.